Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection
- PMID: 20564338
- DOI: 10.1002/jps.22255
Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection
Abstract
Cytochrome P450 (CYP) proteins are involved in the biological oxidation and reduction of xenobiotics, affecting the pharmacological efficiency of drugs. This study aimed to establish a method to simultaneously quantify 11 CYP isoforms by multiplexed-multiple reaction monitoring analysis with liquid chromatography tandem mass spectrometry and in silico peptide selection to clarify CYP isoform expression profiles in human liver tissue. CYP1A2, 2A6, and 2D6 target peptides were identified by shot-gun proteomic analysis, and those of other isoforms were selected by in silico peptide selection criteria. The established quantification method detected target peptides at 10 fmol, and the dynamic range of calibration curves was at least 500-fold. The quantification value of CYP1A2 in Supersomes was not significantly different between the established method and quantitative immunoblot analysis. The absolute protein expression levels of 11 CYP isoforms were determined from one pooled and 10 individual human liver microsomes. In the individual microsomes, CYP2C9 showed the highest protein expression level, and CYP1A2, 2A6, 2C19, and 3A4 protein expression exhibited more than a 20-fold difference among individuals. This highly sensitive and selective quantification method is a useful tool for the analysis of highly homologous CYP isoforms and the contribution made by each CYP isoform to drug metabolism.
Copyright © 2010 Wiley-Liss, Inc. and the American Pharmacists Association
Similar articles
-
Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.J Pharm Biomed Anal. 2014 Nov;100:393-401. doi: 10.1016/j.jpba.2014.08.016. Epub 2014 Aug 17. J Pharm Biomed Anal. 2014. PMID: 25218440
-
The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.Eur Neuropsychopharmacol. 2004 May;14(3):199-208. doi: 10.1016/S0924-977X(03)00105-6. Eur Neuropsychopharmacol. 2004. PMID: 15056479
-
Inhibition of cytochrome P450 by ethambutol in human liver microsomes.Toxicol Lett. 2014 Aug 17;229(1):33-40. doi: 10.1016/j.toxlet.2014.06.006. Epub 2014 Jun 5. Toxicol Lett. 2014. PMID: 24910189
-
Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometry.Curr Drug Metab. 2008 Jan;9(1):12-9. doi: 10.2174/138920008783331112. Curr Drug Metab. 2008. PMID: 18220567 Review.
-
[Progress in quantitative methods based on liquid chromatography-mass spectrometry for drug metabolizing enzymes in human liver microsomes].Se Pu. 2015 Jun;33(6):553-7. doi: 10.3724/sp.j.1123.2015.03023. Se Pu. 2015. PMID: 26536756 Review. Chinese.
Cited by
-
Mass spectrometry-based quantification of CYP enzymes to establish in vitro/in vivo scaling factors for intestinal and hepatic metabolism in beagle dog.Pharm Res. 2012 Jul;29(7):1832-42. doi: 10.1007/s11095-012-0707-7. Epub 2012 Feb 22. Pharm Res. 2012. PMID: 22354837
-
Simultaneous absolute protein quantification of seven cytochrome P450 isoforms in rat liver microsomes by LC-MS/MS-based isotope internal standard method.Front Pharmacol. 2022 Aug 17;13:906027. doi: 10.3389/fphar.2022.906027. eCollection 2022. Front Pharmacol. 2022. PMID: 36059965 Free PMC article.
-
Targeted CYP2E1 quantification and its correlation to currently acceptable clinical biochemical indices.J Biol Res (Thessalon). 2016 Jun 30;23:15. doi: 10.1186/s40709-016-0052-9. eCollection 2016 Dec. J Biol Res (Thessalon). 2016. PMID: 27376033 Free PMC article.
-
Comparative Proteomics Analysis of Human Liver Microsomes and S9 Fractions.Drug Metab Dispos. 2020 Jan;48(1):31-40. doi: 10.1124/dmd.119.089235. Epub 2019 Nov 7. Drug Metab Dispos. 2020. PMID: 31699809 Free PMC article.
-
Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8.Drug Metab Dispos. 2019 Apr;47(4):436-443. doi: 10.1124/dmd.118.085498. Epub 2019 Feb 1. Drug Metab Dispos. 2019. PMID: 30709838 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
